arrow_back Back to App

Diagnostics Testing Preparedness Plan: Faster Response to Health Threats

This act aims to streamline the development and distribution of diagnostic tests during public health crises, such as pandemics. It ensures citizens will have faster access to essential tests, improving safety and response effectiveness. The act promotes better coordination among various entities to ensure tests are available where most needed.
Key points
Faster Test Access: The act mandates a plan to accelerate the development, manufacturing, and distribution of diagnostic tests during health crises.
Increased Accessibility: The plan will consider novel technologies like at-home and point-of-care tests to make them more readily available to everyone.
Public-Private Collaboration: The act encourages cooperation between the government and private companies to boost domestic test production capacity and ensure availability in emergencies.
Regular Updates: The plan will be publicly released and updated at least every three years to adapt to evolving needs and technologies.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_1108
Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-1]
Process start date: 2025-02-07
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Diagnostics Testing Preparedness Plan Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_1108.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-02-07.

What are the main provisions?

Key points include:

  • Faster Test Access: The act mandates a plan to accelerate the development, manufacturing, and distribution of diagnostic tests during health crises.
  • Increased Accessibility: The plan will consider novel technologies like at-home and point-of-care tests to make them more readily available to everyone.
  • Public-Private Collaboration: The act encourages cooperation between the government and private companies to boost domestic test production capacity and ensure availability in emergencies.
  • Regular Updates: The plan will be publicly released and updated at least every three years to adapt to evolving needs and technologies.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Miller-Meeks, Mariannette [R-IA-1].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health